ASCL1 Restrains ERK1/2 to Promote Survival of a Subset of Neuroendocrine Lung Cancers. Martin-Vega A, Earnest SA, Augustyn A, Wichaidit C, et al. Mol Cancer Ther 2024;23:1789-1800.

Read + Share

Amedeo Smart

Independent Medical Education

Martin-Vega A, Earnest SA, Augustyn A, Wichaidit C, et al. ASCL1 Restrains ERK1/2 to Promote Survival of a Subset of Neuroendocrine Lung Cancers. Mol Cancer Ther 2024;23:1789-1800.
PMID: 39295275